Related references
Note: Only part of the references are listed.Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
Mansoor N. Saleh et al.
BLOOD (2013)
ITP: hematology's Cosette from Les Miserables
V. Koneti Rao
BLOOD (2013)
Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia
Sif Gudbrandsdottir et al.
BLOOD (2013)
Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group
Francesco Rodeghiero et al.
BLOOD (2013)
Repeated short-term use of eltrombopag in patients with chronic immune thrombocytopenia (ITP)
James B. Bussel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia
David Gomez-Almaguer et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
Pathophysiology and management of primary immune thrombocytopenia
Hirokazu Kashiwagi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists
Bahareh Ghadaki et al.
TRANSFUSION (2013)
Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care
David J. Kuter et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters
Lisa J. Toltl et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group
Thomas Kuehne et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia
Zhenyu Li et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
Gregory Cheng et al.
LANCET (2011)
Advances in ITP - Therapy and Quality of Life - A Patient Survey
Axel C. Matzdorff et al.
PLOS ONE (2011)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia
Francesco Zaja et al.
BLOOD (2010)
Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents
Weili Bao et al.
BLOOD (2010)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
YF Cheng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
